These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33483844)

  • 21. The risk of thyroid cancer and obesity: A nationwide population-based study using the Korea National Health Insurance Corporation cohort database.
    Son H; Lee H; Kang K; Lee I
    Surg Oncol; 2018 Jun; 27(2):166-171. PubMed ID: 29937167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiotherapy for primary thyroid cancer as a risk factor for second primary cancers.
    Chuang SC; Hashibe M; Yu GP; Le AD; Cao W; Hurwitz EL; Rao JY; Neugut AI; Zhang ZF
    Cancer Lett; 2006 Jul; 238(1):42-52. PubMed ID: 16039041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Markedly increased risk of malignancies in women with endometriosis.
    Eoh KJ; Han M; Kim EH; Jung I; Kim YT
    Gynecol Oncol; 2021 Apr; 161(1):291-296. PubMed ID: 33514482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiation and Second Primary Thyroid Cancer Following Index Head and Neck Cancer.
    Polednik KM; Simpson MC; Adjei Boakye E; Mohammed KA; J Dombrowski J; Varvares MA; Osazuwa-Peters N
    Laryngoscope; 2019 Apr; 129(4):1014-1020. PubMed ID: 30208210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of iodinated contrast agent administered during preoperative computed tomography scan on body iodine pool in patients with differentiated thyroid cancer preparing for radioactive iodine treatment.
    Sohn SY; Choi JH; Kim NK; Joung JY; Cho YY; Park SM; Kim TH; Jin SM; Bae JC; Lee SY; Chung JH; Kim SW
    Thyroid; 2014 May; 24(5):872-7. PubMed ID: 24295076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer.
    Brown AP; Chen J; Hitchcock YJ; Szabo A; Shrieve DC; Tward JD
    J Clin Endocrinol Metab; 2008 Feb; 93(2):504-15. PubMed ID: 18029468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. J-Shaped Association Between Postoperative Levothyroxine Dosage and Fracture Risk in Thyroid Cancer Patients: A Retrospective Cohort Study.
    Shin DW; Suh B; Lim H; Yun JM; Song SO; Park Y
    J Bone Miner Res; 2018 Jun; 33(6):1037-1043. PubMed ID: 29447437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for second primary malignancies following thyroid cancer: a nationwide cohort study.
    Kim M; Kim H; Park S; Joo J; Kim IJ; Kim BH
    Eur J Endocrinol; 2022 Apr; 186(5):561-571. PubMed ID: 35286279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Actual causes of death in thyroid cancer patients in Korea: A Nationwide Case Control Cohort Study.
    Kim KJ; Jang S; Kim KJ; An JH; Kim NH; Shin DY; Yoo HJ; Kim HY; Seo JA; Kim NH; Lee J; Choi KM; Baik SH; Kim SG
    Eur J Endocrinol; 2020 Jan; 182(1):103-110. PubMed ID: 31721722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What is the relationship between the local population change and cancer incidence in patients with dyslipidemia: Evidence of the impact of local extinction in Korea.
    Jeong W; Choi DW; Kim W; Han KT
    Cancer Med; 2024 Apr; 13(7):e7169. PubMed ID: 38597133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonthyroidal second primary malignancies in differentiated thyroid cancer patients: Is the incidence increased comparing to the general population and could it be a radioiodine therapy consequence?
    Cappagli V; Caldarella A; Manneschi G; Piaggi P; Bottici V; Agate L; Molinaro E; Bianchi F; Elisei R
    Int J Cancer; 2020 Nov; 147(10):2838-2846. PubMed ID: 32449158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of thyroid carcinoma in a female population after radiotherapy for breast carcinoma.
    Huang J; Walker R; Groome PG; Shelley W; Mackillop WJ
    Cancer; 2001 Sep; 92(6):1411-8. PubMed ID: 11745217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk Factors for Thyroid Cancer: A Hospital-Based Case-Control Study in Korean Adults.
    Myung SK; Lee CW; Lee J; Kim J; Kim HS
    Cancer Res Treat; 2017 Jan; 49(1):70-78. PubMed ID: 27338034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of second primary malignancies in women with papillary thyroid cancer.
    Canchola AJ; Horn-Ross PL; Purdie DM
    Am J Epidemiol; 2006 Mar; 163(6):521-7. PubMed ID: 16421240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exposure to radiotherapy for first primary cancer as a risk factor for second primary thyroid cancer: A case-control study.
    Cuellar Cuellar AA; Cuellar Rivera DI; Fierro-Maya LF; Posso Valencia H
    Ann Endocrinol (Paris); 2020 Dec; 81(6):539-544. PubMed ID: 33290749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis.
    Sawka AM; Thabane L; Parlea L; Ibrahim-Zada I; Tsang RW; Brierley JD; Straus S; Ezzat S; Goldstein DP
    Thyroid; 2009 May; 19(5):451-7. PubMed ID: 19281429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of non-Hodgkin's lymphoma and thyroid cancer in primary Sjögren's syndrome measured using the Korean Health Insurance Claims Database.
    Ahn JK; Hwang J; Seo GH
    Clin Exp Rheumatol; 2020; 38 Suppl 126(4):40-46. PubMed ID: 31969226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. (131)I treatment for thyroid cancer and the risk of developing salivary and lacrimal gland dysfunction and a second primary malignancy: a nationwide population-based cohort study.
    Ko KY; Kao CH; Lin CL; Huang WS; Yen RF
    Eur J Nucl Med Mol Imaging; 2015 Jul; 42(8):1172-8. PubMed ID: 25900274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thyroid adenomas after solid cancer in childhood.
    Haddy N; El-Fayech C; Guibout C; Adjadj E; Thomas-Teinturier C; Oberlin O; Veres C; Pacquement H; Jackson A; Munzer M; N'Guyen TD; Bondiau PY; Berchery D; Laprie A; Bridier A; Lefkopoulos D; Schlumberger M; Rubino C; Diallo I; de Vathaire F
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):e209-15. PubMed ID: 22672756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and death rate of sarcoidosis in Korea in association with metabolic diseases.
    Choi JY; Lee JH; Seo JM; Yun SY; Koo HYR; Yu DS; Lee YB
    J Dermatol; 2022 May; 49(5):488-495. PubMed ID: 35040161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.